bpc-157 human clinical evidence safety regulatory status FDA advisory committee votes to add popular peptide to drug compounding list bpc-157 human clinical trials evidence

It is not intended for human consumption, therapeutic use, or medical application

Peptides administered via injection remain intact longer, making them easier for your body to use

It's not complicated, but it does demand diligence

Vitamin B12 injections are the most common and effective way to prevent and treat a deficiency

Note: This compound is strictly for in-vitro laboratory research use only and is not for human consumption, diagnostic, or therapeutic purposes

GHK-Cu, a copper-binding tripeptide first isolated from human plasma by Pickart in 1973, is one of the most thoroughly studied peptides in skin biology, with published research demonstrating its influence on collagen synthesis, antioxidant enzyme regulation, and the expression of over 4,000 human genes